Nemolizumab in moderate to severe atopic dermatitis: An exploratory analysis of work productivity and activity impairment in a randomized phase II study

Atopic dermatitis negatively impacts work productivity. This study investigated the impact of nemolizumab on work productivity and activity impairment in adults with moderate to severe atopic dermatitis inadequately controlled by topical treatments in a two‐part, phase II, randomized control trial....

Descripción completa

Detalles Bibliográficos
Autores principales: Mihara, Ryosuke, Kabashima, Kenji, Furue, Masutaka, Nakano, Miwa, Ruzicka, Thomas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6771858/
https://www.ncbi.nlm.nih.gov/pubmed/31166620
http://dx.doi.org/10.1111/1346-8138.14934

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6771858/
https://www.ncbi.nlm.nih.gov/pubmed/31166620
http://dx.doi.org/10.1111/1346-8138.14934

Ejemplares similares